217 related articles for article (PubMed ID: 12347032)
1. Dealing with Depo: you can manage bleeding with estrogen, ibuprofen.
Contracept Technol Update; 1995 Dec; 16(12):145-8. PubMed ID: 12347032
[TBL] [Abstract][Full Text] [Related]
2. Managing menstrual disturbances.
Barnett B
Netw Res Triangle Park N C; 1995 Jun; 15(4):8. PubMed ID: 12289833
[TBL] [Abstract][Full Text] [Related]
3. Counseling for Depo a must.
Family Plan World; 1993; ():8. PubMed ID: 12290813
[TBL] [Abstract][Full Text] [Related]
4. Depo-Provera highly effective as injectable contraceptive.
Denniston GC
Contracept Technol Update; 1985 Dec; 6(12):167-8. PubMed ID: 12280301
[TBL] [Abstract][Full Text] [Related]
5. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
American Health Consultants
Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
[TBL] [Abstract][Full Text] [Related]
6. Depo-provera: clinical evaluation.
Mukherjea M
Contracept Deliv Syst; 1981 Jul; 2(3):259-69. PubMed ID: 12278913
[TBL] [Abstract][Full Text] [Related]
7. [Depo-provera as a long-term contraceptive].
Janaud A
Contracept Fertil Sex (Paris); 1974 Mar; 2(2):95-104. PubMed ID: 12333651
[TBL] [Abstract][Full Text] [Related]
8. Medicolegal issues surrounding Depo-Provera easily overcome.
Contracept Technol Update; 1992 Jan; 13(1):16, 18. PubMed ID: 12343460
[TBL] [Abstract][Full Text] [Related]
9. Not FDA-approved, but experts recommend Depo-Provera.
Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
[TBL] [Abstract][Full Text] [Related]
10. [Indications and medical survey of long acting progestatives used for contraception (author's transl)].
Molitor-peffer MP
Contracept Fertil Sex (Paris); 1982 Oct; 10(10):665-8. PubMed ID: 12338449
[TBL] [Abstract][Full Text] [Related]
11. Are Norplant, Depo-Provera good options for nursing mothers?
Contracept Technol Update; 1993 Mar; 14(3):46-8. PubMed ID: 12318085
[TBL] [Abstract][Full Text] [Related]
12. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
13. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects.
Basnayake S; Thapa S
Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188
[TBL] [Abstract][Full Text] [Related]
14. Ask the experts: progestin-only contraceptives.
Hatcher RA; Schnare S
Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
[TBL] [Abstract][Full Text] [Related]
15. Use of a long-acting injectable contraceptive in a postpartum family planning program.
Mcdaniel EB; Pardthaisong T
Asian J Med; 1973 Apr; 9(4):133-5. PubMed ID: 12262537
[TBL] [Abstract][Full Text] [Related]
16. New year, new option: Cyclo-Provera awaits word.
Contracept Technol Update; 1998 Jan; 19(1):3-4. PubMed ID: 12348212
[TBL] [Abstract][Full Text] [Related]
17. Three-monthly Depo-Provera in Mexico.
Correu Azcona S
IPPF Med Bull; 1977 Jun; 11(3):2-3. PubMed ID: 12335212
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment counseling keeps patients on Depo.
Contracept Technol Update; 1997 Oct; 18(10):125-6. PubMed ID: 12321212
[TBL] [Abstract][Full Text] [Related]
19. Depo-Provera: just another contraceptive?
Jones M
Fertil Contracept; 1978 Apr; 2(2):26-9. PubMed ID: 12336094
[TBL] [Abstract][Full Text] [Related]
20. 3-month contraceptive injection approved.
FDA Med Bull; 1993 Mar; 23(1):6-7. PubMed ID: 12318115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
